Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.

Trial Profile

Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 25 May 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Earache
  • Focus Therapeutic Use
  • Acronyms LYRORL
  • Most Recent Events

    • 17 May 2017 Planned End Date changed from 1 May 2017 to 1 May 2018.
    • 17 May 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.
    • 07 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top